Net Deals Web Search

  1. Ads

    related to: eli lilly and company mounjaro shortage list of products

Search results

  1. Results From The WOW.Com Content Network
  2. Some doses of Lilly's Mounjaro in tight supply through April ...

    www.aol.com/news/doses-lillys-mounjaro-tight...

    April 2, 2024 at 9:22 AM. (Reuters) - Four doses of Eli Lilly's diabetes drug Mounjaro would remain in tight supply through 2024 due to soaring demand, the U.S. Food and Drug Administration's ...

  3. FDA website shows limited availability of some doses of Lilly ...

    www.aol.com/news/fda-website-shows-limited...

    February 5, 2024 at 12:52 PM. (Reuters) -The U.S. Food and Drug Administration's (FDA) website showed that three higher doses of Eli Lilly's diabetes drug, Mounjaro, would be available only in ...

  4. Lilly's Mounjaro dose in limited availability in US ... - AOL

    www.aol.com/news/lillys-mounjaro-dose-limited...

    A dose of Eli Lilly's diabetes drug Mounjaro has limited availability through February 2024, according to the U.S. Food and Drug Administration's website, due to an increase in demand. The high ...

  5. Most of Lilly's Mounjaro and Zepbound doses in limited ... - AOL

    www.aol.com/news/most-doses-lillys-mounjaro-zep...

    April 17, 2024 at 1:51 PM. (Reuters) -Most doses of Eli Lilly's diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to ...

  6. Eli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024

    www.aol.com/finance/eli-lilly-reports-2-billion...

    Eli Lilly missed Wall Street consensus estimates on Mounjaro sales for the first quarter of the year, but its GLP-1 products, including Zepbound, still contributed to 26% sales growth year over ...

  7. US FDA warns website over unlawful sale of weight-loss drugs

    www.aol.com/news/us-fda-warns-website-over...

    Surging demand has outpaced supply for Novo's Ozempic, Eli Lilly's Mounjaro and other GLP-1 drugs that promote weight loss, fueling a growing global market for counterfeit versions. The FDA said ...

  8. How the CFOs of Eli Lilly and Novo Nordisk are coping with ...

    www.aol.com/finance/cfos-eli-lilly-novo-nordisk...

    Indianapolis-based Eli Lilly (no. 142 on the Fortune 500) is the maker of Mounjaro, classified as Type 2 diabetes drug but which has led to weight loss among patients, and Zepbound, an obesity ...

  9. Eli Lilly cracks down on the use of weight loss drugs ... - AOL

    www.aol.com/finance/eli-lilly-cracks-down-weight...

    Eli Lilly and Co. on Thursday warned against use of its popular diabetes and weight loss drugs Mounjaro and Zepbound for “cosmetic” reasons. The news comes as rampant demand for the reputed ...

  1. Ads

    related to: eli lilly and company mounjaro shortage list of products